| # | Drug | Count |
|---|---|---|
| 0 | VALACYCLOVIR HYDROCHLORIDE | 468 |
| 1 | METHOTREXATE SODIUM | 416 |
| 2 | PREDNISONE | 396 |
| 3 | METHOTREXATE | 381 |
| 4 | ADALIMUMAB | 345 |
| 5 | OCRELIZUMAB | 255 |
| 6 | ACYCLOVIR | 251 |
| 7 | ETANERCEPT | 251 |
| 8 | DUPILUMAB | 229 |
| 9 | MYCOPHENOLATE MOFETIL | 222 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TALIMOGENE LAHERPAREPVEC | 37 | 0.0233 |
| 1 | ADALIMUMAB-AACF | 5 | 0.0149 |
| 2 | VALACYCLOVIR HYDROCHLORIDE | 468 | 0.0065 |
| 3 | TREOSULFAN | 13 | 0.0047 |
| 4 | PRALSETINIB | 8 | 0.0044 |
| 5 | OCRELIZUMAB | 255 | 0.0041 |
| 6 | SELENIUM | 17 | 0.0040 |
| 7 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 11 | 0.0040 |
| 8 | ACYCLOVIR SODIUM | 5 | 0.0040 |
| 9 | DEFLAZACORT | 9 | 0.0035 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Macrolide Antibacterial [EPC] | 6 | 0.0059 |
| 1 | Benzodiazepine Antagonist [EPC] | 3 | 0.0034 |
| 2 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 58 | 0.0030 |
| 4 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 11 | 0.0023 |
| 6 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 253 | 0.0022 |
| 7 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 257 | 0.0022 |
| 8 | CD4-directed Blocking Antibody [EPC] | 1 | 0.0019 |
| 9 | Melanin Synthesis Inhibitor [EPC] | 2 | 0.0018 |